Investors / Negev Capital
Negev Capital
Venture capital
Negev Capital is a biotech venture fund focused on CNS and brain health therapeutics. It is fully invested and now builds new CNS companies through its venture studio, Palomar Labs.
Invests inHealthcare & Biotech
In its own wordscnsbrain healthbiotechpsychedelicsneuropsychiatrydrug development
Your fit with Negev Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsNegev Capital lists 14 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (93%) and Robotics & Hardware (7%). 88% of its companies are based in United States. It invests most often alongside Palo Santo, PsyMed Ventures and Noetic Fund.
No funding round on record names Negev Capital yet, so the figures come from its portfolio page.
Round figures show recent activity, not Negev Capital's whole history. Rounds on record name 0 companies; its own site lists 14. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 36th | 14 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 96th | 93% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1393%
- No longer answers00%
- Points to another company17%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 93% | 15% |
| Robotics & Hardware | 7% | 1% |
Co-investor network
who it backs companies with, and who they back togetherCompare Negev Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its sitePortfolio
14 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| A Better Life Pharma is an emerging biotechnology company focused on developing and commercializing patient-friendly compounds to treat neuro-psychiatric and neurological disorders. | Healthcare & Biotech | Portfolio page | ||
| Ariadne Bio is developing AB-300, an investigational serotonergic therapy for apathy in Parkinson's disease. | Healthcare & Biotech | Portfolio page | ||
| AtaiBeckley develops mental health treatments | Healthcare & Biotech | Portfolio page | ||
| Biomind Labs develops novel drugs for the medical treatment of neurological disorders | Healthcare & Biotech | Portfolio page | ||
| Bright Minds develops drugs for mental health and neurology | Healthcare & Biotech | Portfolio page | ||
| Helus Pharma develops novel serotonergic agonists for the treatment of mental health conditions | Healthcare & Biotech | Portfolio page | ||
| Delix Therapeutics is developing novel therapeutics to address brain health challenges | Healthcare & Biotech | Portfolio page | ||
| Freedom Biosciences is a biotechnology platform developing next-generation neuropsychiatric therapeutics. | Healthcare & Biotech | Portfolio page | ||
| Gilgamesh Pharma develops innovative new chemical entities to transform the treatment paradigm of psychiatric disease | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Mindstate Design Labs designs and develops psychoactive substances using molecular design and engineering techniques. | Healthcare & BiotechRobotics & Hardware | Portfolio page | ||
| Psylo is a biotechnology company developing neuroplastogens, a novel class of therapies that restore brain function by stimulating the growth and remodeling of neural circuits | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Reset Pharma is a neuro-biotechnology company dedicated to improving mental health through novel pathways. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- negevcap.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 14
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Negev Capital's profile as data
Pull Negev Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/negevcap.com
# also
GET /v1/firms/negevcap.com/portfolio
GET /v1/firms/negevcap.com/coinvestors
GET /v1/firms/negevcap.com/news